Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
gnc-035 (2 trials)
gnc-038 (1 trial)
gnc-039 (1 trial)
si-b001 (1 trial)
si-b003 (1 trial)
si-f019 (1 trial)
Lymphoma (Phase 1)
Lymphoma, Non-Hodgkin (Phase 1)
Neoplasms (Phase 1)
Neoplasms, Glandular and Epithelial (Phase 1)
Trials (7 total)
Trial APIs (6 total)